Search

A new daily pill, orforglipron, could aid individuals in maintaining weight loss after discontinuing injectable weight-loss medications, with a study showing participants who took the pill daily during a year retained over 70% of their previous weight loss compared to 38-50% in those on a placebo, while also potentially mitigating long-term obesity-related health risks. #WeightLoss #ObesityTreatment #ChronicDisease #US #GB

Aprobamos una reforma del copago farmacéutico para blindar la equidad y proteger a las rentas medias y bajas. Muy importante para aquellos pacientes con enfermedades crónicas y tratamientos prolongados: https://t.co/92xN1vLf1M #PharmaceuticalReform #HealthcareEquity #ChronicDiseases #Nospecificcountrycodescanbeextractedfromthetweetprovided.

Fast die Hälfte der Deutschen im mittleren Lebensalter leidet an zwei oder mehr chronischen Erkrankungen, wobei regionale Unterschiede und Risikofaktoren wie Bewegungsmangel, Rauchen und Alkoholkonsum eine bedeutende Rolle spielen. #ChronicDiseases #Multimorbidity #HealthInequality

The article emphasizes that obesity is a chronic, progressive, and multifactorial condition requiring continuous management rather than short-term solutions, highlighting the importance of long-term medication usage, such as semaglutide and tirzepatide, alongside lifestyle changes and multidisciplinary support to effectively control the disease and prevent weight regain. #ObesityManagement #ChronicDisease #HealthcareSolutions #BR #US

Celebrated on April 26, the National Day for the Prevention and Combat of Arterial Hypertension in Brazil highlights the chronic condition affecting approximately 30% of the adult population, which is a leading cause of serious cardiovascular issues and emphasizes the importance of regular monitoring and lifestyle changes to manage and prevent this "silent" disease. #Hypertension #HealthAwareness #ChronicDisease